DowDuPont Inc (DWDP) Earns “Hold” Rating from SunTrust Banks, Inc.
DowDuPont Inc (NASDAQ:DWDP)‘s stock had its “hold” rating reiterated by investment analysts at SunTrust Banks, Inc. in a research report issued to clients and investors on Friday. They currently have a $73.00 price objective on the stock. SunTrust Banks, Inc.’s price objective indicates a potential upside of 4.33% from the stock’s current price. SunTrust Banks also issued estimates for DowDuPont’s Q4 2017 earnings at $0.68 EPS, FY2017 earnings at $3.25 EPS, FY2018 earnings at $3.82 EPS and FY2019 earnings at $4.44 EPS.
A number of other analysts also recently weighed in on DWDP. Credit Suisse Group increased their price target on shares of DowDuPont from $79.00 to $82.00 and gave the company an “outperform” rating in a report on Friday, November 3rd. UBS AG increased their price target on shares of DowDuPont from $82.00 to $85.00 and gave the company a “buy” rating in a report on Friday, November 3rd. Morgan Stanley increased their price target on shares of DowDuPont from $77.00 to $80.00 and gave the company an “overweight” rating in a report on Wednesday, November 1st. Cowen and Company initiated coverage on shares of DowDuPont in a report on Friday, September 1st. They set a “market perform” rating for the company. Finally, Monness Crespi & Hardt initiated coverage on shares of DowDuPont in a report on Tuesday, September 12th. They set a “neutral” rating for the company. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and seventeen have assigned a buy rating to the stock. DowDuPont has an average rating of “Buy” and an average target price of $79.72.
Shares of DowDuPont (DWDP) traded down $0.26 during trading on Friday, reaching $69.97. 7,118,712 shares of the company’s stock were exchanged, compared to its average volume of 6,910,000. DowDuPont has a 12-month low of $64.01 and a 12-month high of $73.85.
DowDuPont (NASDAQ:DWDP) last issued its quarterly earnings results on Thursday, November 2nd. The company reported $0.55 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.55. The company had revenue of $18.29 billion during the quarter, compared to the consensus estimate of $18.24 billion. During the same period last year, the company earned $0.91 earnings per share. DowDuPont’s revenue for the quarter was up 7.6% on a year-over-year basis.
In related news, General Counsel Charles J. Kalil sold 78,895 shares of the stock in a transaction dated Tuesday, November 7th. The shares were sold at an average price of $71.00, for a total transaction of $5,601,545.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Several institutional investors have recently made changes to their positions in the stock. Wells Fargo & Company MN acquired a new stake in shares of DowDuPont during the 3rd quarter worth about $1,111,269,000. Ropes Wealth Advisors LLC acquired a new stake in shares of DowDuPont during the 3rd quarter worth about $6,259,000. Budros Ruhlin & Roe Inc. acquired a new stake in shares of DowDuPont during the 3rd quarter worth about $219,000. Amalgamated Bank acquired a new stake in shares of DowDuPont during the 3rd quarter worth about $19,004,000. Finally, Auxier Asset Management acquired a new stake in shares of DowDuPont during the 3rd quarter worth about $12,129,000.
DowDuPont Company Profile
DowDuPont Inc is a holding company formed through the merger of equals between The Dow Chemical Company and E. I. du Pont de Nemours and Company (DuPont). The Company’s business divisions include Agriculture division, Material Science division, and a Specialty Products division. The Agriculture Division offers a complete portfolio of products and technologies, and a pipeline of germplasm, traits and crop protection.
Receive News & Ratings for DowDuPont Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DowDuPont Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.